| dc.creator |
Bentley, J. Nicole |
|
| dc.creator |
Viswanathan, Ashwin |
|
| dc.creator |
Rosenberg, William S. |
|
| dc.creator |
Patil, Parag G. |
|
| dc.date |
2014-10-07T16:09:18Z |
|
| dc.date |
WITHHELD_12_MONTHS |
|
| dc.date |
2014-10-07T16:09:18Z |
|
| dc.date |
2014-09 |
|
| dc.date.accessioned |
2022-05-19T10:34:53Z |
|
| dc.date.available |
2022-05-19T10:34:53Z |
|
| dc.identifier |
Bentley, J. Nicole; Viswanathan, Ashwin; Rosenberg, William S.; Patil, Parag G. (2014). "Treatment of Medically Refractory Cancer Pain with a Combination of Intrathecal Neuromodulation and Neurosurgical Ablation: Case Series and Literature Review." Pain Medicine (9): 1488-1495. |
|
| dc.identifier |
1526-2375 |
|
| dc.identifier |
1526-4637 |
|
| dc.identifier |
https://hdl.handle.net/2027.42/108610 |
|
| dc.identifier |
10.1111/pme.12481 |
|
| dc.identifier |
Pain Medicine |
|
| dc.identifier |
Hodge CJ Jr, Christensen M. Anterolateral Cordotomy. In: Burchiel KJ, ed. Surgical Management of Pain. New York, NY: Thieme; 2002: 732 – 744. |
|
| dc.identifier |
Gildenberg PL. Myelotomy and percutaneous cervical cordotomy for the treatment of cancer pain. Appl Neurophysiol 1984; 47: 208 – 215. |
|
| dc.identifier |
Lahuerta J, Lipton S, Wells JC. Percutaneous cervical cordotomy: Results and complications in a recent series of 100 patients. Ann R Coll Surg Engl 1985; 67: 41 – 44. |
|
| dc.identifier |
Romanelli P, Esposito V, Adler J. Ablative procedures for chronic pain. Neurosurg Clin N Am 2004; 15: 335 – 342. |
|
| dc.identifier |
Sanders M, Zuurmond W. Safety of unilateral and bilateral percutaneous cervical cordotomy in 80 terminally ill cancer patients. J Clin Oncol 1995; 13: 1509 – 1512. |
|
| dc.identifier |
Collins KL, Patil PG. Flat‐panel fluoroscopy O‐arm‐guided percutaneous radiofrequency cordotomy: A new technique for the treatment of unilateral cancer pain. Neurosurgery 2013; 72 ( 1 suppl Operative ): 27 – 34. |
|
| dc.identifier |
Follett KA. Intrathecal Opioids: Technique and Outcomes. In: Burchiel KJ, ed. Surgical Management of Pain. New York, NY: Thieme; 2002: 614 – 624. |
|
| dc.identifier |
Vilela Filho O, Araujo MR, Florencio RS, Silva MA, Silveira MT. CT‐guided percutaneous punctate midline myelotomy for the treatment of intractable visceral pain: A technical note. Stereotact Funct Neurosurg 2001; 77: 177 – 182. |
|
| dc.identifier |
Viswanathan A, Burton AW, Rekito A, McCutcheon IE. Commissural myelotomy in the treatment of intractable visceral pain: Technique and outcomes. Stereotact Funct Neurosurg 2010; 88: 374 – 382. |
|
| dc.identifier |
Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999; 82: 263 – 274. |
|
| dc.identifier |
Patt RB. Cancer Pain. In: Burchiel KJ, ed. Surgical Management of Pain, 1st edition. New York: Thieme; 2002: 469 – 484. |
|
| dc.identifier |
Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA. Validation of World Health Organization Guidelines for cancer pain relief: A 10‐year prospective study. Pain 1995; 63: 65 – 76. |
|
| dc.identifier |
Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994; 330: 592 – 596. |
|
| dc.identifier |
World Health Organization. Cancer Pain Relief, 1st edition. Geneva, Switzerland: World Health Organization; 1986. |
|
| dc.identifier |
Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: A 3‐year survey of the German situation. J Pain Symptom Manage 1995; 10: 187 – 191. |
|
| dc.identifier |
Grossman SA, Staats PS. Current management of pain in patients with cancer. Oncology (Williston Park) 1994; 8: 93 – 107. discussion 07, 10, 15. |
|
| dc.identifier |
Yung SW, Lazarus MD, Harryman DT 2nd. Practical guidelines to safe surgery about the subscapularis. J Shoulder Elbow Surg 1996; 5: 467 – 470. |
|
| dc.identifier |
Ripamonti CI, Santini D, Maranzano E, Berti M, Roila F; ESMO Guidelines Working Group. Management of cancer pain: ESMO Clinical Practice Guidelines. Ann Oncol 2012; 23: 139 – 154. |
|
| dc.identifier |
Deer T, Krames ES, Hassenbusch SJ, et al. Polyanalgesic Consensus Conference 2007: Recommendations for the management of pain by intrathecal (intraspinal) drug delivery: Report of an interdisciplinary expert panel. Neuromodulation 2007; 10: 300 – 328. |
|
| dc.identifier |
Patt RB. Cancer Pain. In: Burchiel KJ, ed. Surgical Management of Pain. New York, NY: Thieme; 2002: 469 – 484. |
|
| dc.identifier |
Raphael JH, Southall JL, Gnanadurai TV, Treharne GJ, Kitas GD. Multiple lead spinal cord stimulation for chronic mechanical low back pain: A comparative study with intrathecal opioid drug delivery. Neuromodulation 2004; 7: 260 – 266. |
|
| dc.identifier |
Crul BJ, Blok LM, van Egmond J, van Dongen RT. The present role of percutaneous cervical cordotomy for the treatment of cancer pain. J Headache Pain 2005; 6: 24 – 29. |
|
| dc.identifier |
Collins KL, Taren JA, Patil PG. Four‐decade maintenance of analgesia with percutaneous cordotomy. Stereotact Funct Neurosurg 2012; 90: 266 – 272. |
|
| dc.identifier |
van den Beuken‐van Everdingen MH, de Rijke JM, Kessels AG, et al. Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Ann Oncol 2007; 18: 1437 – 1449. |
|
| dc.identifier |
Daut RL, Cleeland CS. The prevalence and severity of pain in cancer. Cancer 1982; 50: 1913 – 1918. |
|
| dc.identifier |
Foley KM. The treatment of cancer pain. N Engl J Med 1985; 313: 84 – 95. |
|
| dc.identifier |
Maltoni M. Opioids, pain, and fear. Ann Oncol 2008; 19: 5 – 7. |
|
| dc.identifier |
Portenoy RK, Lesage P. Management of cancer pain. Lancet 1999; 353: 1695 – 1700. |
|
| dc.identifier |
Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993; 119: 121 – 126. |
|
| dc.identifier |
Steel TR, Burchiel KJ. Ablative Neurosurgical Techniques in the Treatment of Chronic Pain: Overview, 1st edition. New York, NY: Thieme; 2002. |
|
| dc.identifier |
Raslan AM, Cetas JS, McCartney S, Burchiel KJ. Destructive procedures for control of cancer pain: The case for cordotomy. J Neurosurg 2011; 114: 155 – 170. |
|
| dc.identifier |
Spiller W, Martin E. The treatment of persistent pain of organic origin in the lower part of the body by division of the anterolateral column of the spinal cord. JAMA 1912; 58: 1489 – 1490. |
|
| dc.identifier |
Kanpolat Y, Deda H, Akyar S, Bilgic S. CT‐guided percutaneous cordotomy. Acta Neurochir Suppl (Wien) 1989; 46: 67 – 68. |
|
| dc.identifier |
Kanpolat Y, Ugur HC, Ayten M, Elhan AH. Computed tomography‐guided percutaneous cordotomy for intractable pain in malignancy. Neurosurgery 2009; 64 ( suppl 3 ): ons187 – 194. |
|
| dc.identifier |
Mullan S, Harper P, Hekmatpanah J, Torres H, Dobbin G. Percutaneous interruption of spinal pain tracts by means of a strontium 90 needle. J Neurosurg 1963; 20: 931 – 939. |
|
| dc.identifier |
Raslan AM, Cetas JS, McCartney S, Burchiel KJ. Destructive procedures for control of cancer pain: The case for cordotomy. J Neurosurg 2010; 114: 155 – 170. |
|
| dc.identifier |
Nauta HJW, Westlund KN, Willis WD. Midline Myelotomy, 1st edition. New York, NY: Thieme; 2002. |
|
| dc.identifier |
Wang JK, Nauss LA, Thomas JE. Pain relief by intrathecally applied morphine in man. Anesthesiology 1979; 50: 149 – 151. |
|
| dc.identifier |
Rauck RL, Cherry D, Boyer MF, et al. Long‐term intrathecal opioid therapy with a patient‐activated, implanted delivery system for the treatment of refractory cancer pain. J Pain 2003; 4: 441 – 447. |
|
| dc.identifier |
Sjostrom S, Tamsen A, Persson MP, Hartvig P. Pharmacokinetics of intrathecal morphine and meperidine in humans. Anesthesiology 1987; 67: 889 – 895. |
|
| dc.identifier |
Smith TJ, Staats PS, Deer T, et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug‐related toxicity, and survival. J Clin Oncol 2002; 20: 4040 – 4049. |
|
| dc.identifier |
World Health Organization. Cancer Pain Relief, 1st edition. Geneva, Switzerland: World Health Organization; 1986. |
|
| dc.identifier |
Deandrea S, Montanari M, Moja L, Apolone G. Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol 2008; 19: 1985 – 1991. |
|
| dc.identifier |
Newsome S, Frawley BK, Argoff CE. Intrathecal analgesia for refractory cancer pain. Curr Pain Headache Rep 2008; 12: 249 – 256. |
|
| dc.identifier |
Malhotra VT, Root J, Kesselbrenner J, et al. Intrathecal pain pump infusions for intractable cancer pain: An algorithm for dosing without a neuraxial trial. Anesth Analg 2013; 116: 1364 – 1370. |
|
| dc.identifier |
Lihua P, Su M, Zejun Z, Ke W, Bennett MI. Spinal cord stimulation for cancer‐related pain in adults. Cochrane Database Syst Rev 2013;( 2 ): CD009389. |
|
| dc.identifier |
Hayek SM, Deer TR, Pope JE, Panchal SJ, Patel VB. Intrathecal therapy for cancer and non‐cancer pain. Pain Physician 2011; 14: 219 – 248. |
|
| dc.identifier |
Brogan SE, Winter NB. Patient‐controlled intrathecal analgesia for the management of breakthrough cancer pain: A retrospective review and commentary. Pain Med 2011; 12: 1758 – 1768. |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/100281 |
|
| dc.description |
Objective Up to 90% of patients with advanced cancer experience intractable pain. For these patients, oral analgesics are the mainstay of therapy, often augmented with intrathecal drug delivery. Neurosurgical ablative procedures have become less commonly used, though their efficacy has been well‐established. Unfortunately, little is known about the safety of ablation in the context of previous neuromodulation. Therefore, the aim of this study is to present the results from a case series in which patients were treated successfully with a combination of intrathecal neuromodulation and neurosurgical ablation. Design Retrospective case series and literature review. Setting Three institutions with active cancer pain management programs in the U nited S tates. Methods All patients who underwent both neuroablative and neuromodulatory procedures for cancer pain were surveyed using the visual analog scale prior to the first procedure, before and after a second procedure, and at long‐term follow‐up. Based on initial and subsequent presentation, patients underwent intrathecal morphine pump placement, cordotomy, or midline myelotomy. Results Five patients (2 male, 3 female) with medically intractable pain (initial VAS = 10) were included in the series. Four subjects were initially treated with intrathecal analgesic neuromodulation, and 1 with midline myelotomy. Each patient experienced recurrence of pain ( VAS ≥ 9) following the initial procedure, and was therefore treated with another modality (intrathecal, N = 1; midline myelotomy, N = 1; percutaneous radiofrequency cordotomy, N = 3), with significant long‐term benefit ( VAS 1–7). Conclusion In cancer patients with medically intractable pain, intrathecal neuromodulation and neurosurgical ablation together may allow for more effective control of cancer pain. |
|
| dc.description |
Peer Reviewed |
|
| dc.description |
http://deepblue.lib.umich.edu/bitstream/2027.42/108610/1/pme12481.pdf |
|
| dc.format |
application/pdf |
|
| dc.publisher |
Thieme |
|
| dc.publisher |
Wiley Periodicals, Inc. |
|
| dc.rights |
IndexNoFollow |
|
| dc.subject |
Ablation |
|
| dc.subject |
Surgery |
|
| dc.subject |
Intrathecal |
|
| dc.subject |
Cancer Pain |
|
| dc.subject |
Medicine (General) |
|
| dc.subject |
Health Sciences |
|
| dc.title |
Treatment of Medically Refractory Cancer Pain with a Combination of Intrathecal Neuromodulation and Neurosurgical Ablation: Case Series and Literature Review |
|
| dc.type |
Article |
|